AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-19
DOI
10.1038/s41467-017-02795-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GFAT1 phosphorylation by AMPK promotes VEGF-induced angiogenesis
- (2016) Darya Zibrova et al. BIOCHEMICAL JOURNAL
- O-GlcNAcylation, enemy or ally during cardiac hypertrophy development?
- (2016) Florence Mailleux et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
- (2015) Yow Keat Tham et al. ARCHIVES OF TOXICOLOGY
- Interplay between troponin T phosphorylation and O-N-acetylglucosaminylation in ischaemic heart failure
- (2015) Emilie Dubois-Deruy et al. CARDIOVASCULAR RESEARCH
- Cardiac LXR protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization
- (2015) M. V. Cannon et al. EMBO Molecular Medicine
- Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine
- (2015) Qiuju Huang et al. LIFE SCIENCES
- c-Myc Alters Substrate Utilization and O-GlcNAc Protein Posttranslational Modifications without Altering Cardiac Function during Early Aortic Constriction
- (2015) Dolena Ledee et al. PLoS One
- Variability of Mouse Left Ventricular Function Assessment by 11.7 Tesla MRI
- (2015) Laetitia Vanhoutte et al. Journal of Cardiovascular Translational Research
- A-769662 potentiates the effect of other AMP-activated protein kinase activators on cardiac glucose uptake
- (2014) Aurélie D. Timmermans et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Metformin: From Mechanisms of Action to Therapies
- (2014) Marc Foretz et al. Cell Metabolism
- Cross-talk between Two Essential Nutrient-sensitive Enzymes
- (2014) John W. Bullen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1
- (2014) Gauthier Noppe et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2
- (2013) Fang Ding et al. AMINO ACIDS
- O-GlcNAc Cycling: A Link Between Metabolism and Chronic Disease
- (2013) Michelle R. Bond et al. Annual Review of Nutrition
- Signaling effectors underlying pathologic growth and remodeling of the heart
- (2013) Jop H. van Berlo et al. JOURNAL OF CLINICAL INVESTIGATION
- O-GlcNAc and the cardiovascular system
- (2013) Sujith Dassanayaka et al. PHARMACOLOGY & THERAPEUTICS
- O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy
- (2012) Heberty T. Facundo et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- G 13 -Mediated Signaling Pathway Is Required for Pressure Overload–Induced Cardiac Remodeling and Heart Failure
- (2012) Mikito Takefuji et al. CIRCULATION
- Cardiac O-GlcNAcylation blunts autophagic signaling in the diabetic heart
- (2012) Susan A. Marsh et al. LIFE SCIENCES
- Roles for the Sarco-/Endoplasmic Reticulum in Cardiac Myocyte Contraction, Protein Synthesis, and Protein Quality Control
- (2012) Christopher C. Glembotski PHYSIOLOGY
- Metformin attenuates pressure overload-induced cardiac hypertrophy via AMPK activation
- (2011) Yong-nan Fu et al. ACTA PHARMACOLOGICA SINICA
- Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease
- (2011) Gerald W. Hart et al. Annual Review of Biochemistry
- AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure
- (2011) C. Beauloye et al. CARDIOVASCULAR RESEARCH
- Improvement of Cardiac Functions by Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy in Diabetic OVE26 Mice
- (2011) Z. Xie et al. DIABETES
- Metformin Inhibits Isoproterenol-induced Cardiac Hypertrophy in Mice
- (2011) Hye-Na Cha et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure
- (2011) Ida G. Lunde et al. PHYSIOLOGICAL GENOMICS
- Activation of the cardiac mTOR/p70S6K pathway by leucine requires PDK1 and correlates with PRAS40 phosphorylation
- (2010) Cossette Sanchez Canedo et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- A new regulation of IL-6 production in adult cardiomyocytes by β-adrenergic and IL-1β receptors and induction of cellular hypertrophy by IL-6 trans-signalling
- (2010) Nicolas Szabo-Fresnais et al. CELLULAR SIGNALLING
- AMP-activated protein kinase activator A-769662 is an inhibitor of the Na+-K+-ATPase
- (2009) Boubacar Benziane et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death
- (2009) Gladys A. Ngoh et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- AMPK: Lessons from transgenic and knockout animals
- (2009) Benoit Viollet Frontiers in Bioscience-Landmark
- AMP-activated protein kinase phosphorylates glutamine : fructose-6-phosphate amidotransferase 1 at Ser243 to modulate its enzymatic activity
- (2009) Satoshi Eguchi et al. GENES TO CELLS
- Adiponectin Protects Against Angiotensin II–Induced Cardiac Fibrosis Through Activation of PPAR-α
- (2008) Koichi Fujita et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- AMPKα2 counteracts the development of cardiac hypertrophy induced by isoproterenol
- (2008) Elham Zarrinpashneh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Thienopyridone Drugs Are Selective Activators of AMP-Activated Protein Kinase β1-Containing Complexes
- (2008) John W. Scott et al. CHEMISTRY & BIOLOGY
- O -Linked GlcNAc Modification of Cardiac Myofilament Proteins
- (2008) Genaro A. Ramirez-Correa et al. CIRCULATION RESEARCH
- A769662, a novel activator of AMP-activated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism
- (2008) Daniel Moreno et al. FEBS LETTERS
- AMP Activated Protein Kinase-α2 Deficiency Exacerbates Pressure-Overload–Induced Left Ventricular Hypertrophy and Dysfunction in Mice
- (2008) Ping Zhang et al. HYPERTENSION
- Beyond AICA riboside: In search of new specific AMP-activated protein kinase activators
- (2008) Bruno Guigas et al. IUBMB LIFE
- Up-regulation ofO-GlcNAc Transferase with Glucose Deprivation in HepG2 Cells Is Mediated by Decreased Hexosamine Pathway Flux
- (2008) Rodrick P. Taylor et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AMP-activated Protein Kinase and p38 MAPK ActivateO-GlcNAcylation of Neuronal Proteins during Glucose Deprivation
- (2008) Win D. Cheung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolic Switch and Hypertrophy of Cardiomyocytes following Treatment with Angiotensin II Are Prevented by AMP-activated Protein Kinase
- (2008) Bettina Johanna Stuck et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Resveratrol Inhibits Cardiac Hypertrophy via AMP-activated Protein Kinase and Akt
- (2008) Anita Y. M. Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started